Spinocerebellar Ataxia Type 3 (SCA3) (Machado-Joseph Disease) Gene Mutation Analysis
Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease, is the most common autosomal dominant central nervous system neurodegenerative. SCA3 is divided into 3 forms. SCA3 type 1 (MJD Type 1) associated with ataxia, ophthalmoparesis, pyramidal signs, extrapyramidal signs including dystonia and other movement disorders presenting in adolescence. SCA3 type 2 (MJD Type 2) occurs in middle adulthood with ataxia, spasticity, and dystonia. SCA3 type 3 (MJD Type 3) is common after the age of 40 and includes ophthalmoparesis and anterior horn cell disease, i.e. fasciculations, atrophy, and weakness. A Parkinsonian syndrome can also be associated with SCA3.
This disease is caused by CAG repeat expansion mutation in the ATXN3 gene, which is located on chromosome 14q24.3-q32. The diagnosis of SCA3 requires molecular genetic testing to detect an abnormal CAG trinucleotide repeat in ATXN3 gene. The prevalence of MJD is estimated to be 1-2 in 100,000 with significant geographical and ethnic variations.
- Diagnosis of spinocerebellar ataxia type 3 (SCA3) in patients with cerebellar ataxia
- As an aid in the prenatal diagnosis of Machado-Joseph disease
- To detect the carrier of CAG repeat expansion mutation in the ATXN3 gene
Normal:
- CAG trinucleotide repeats expansion between 13-36
Abnormal:
- CAG trinucleotide repeats expansion between 68-79
Normal: < 44 CAG trinucleotide repeats expansion
Whole blood (EDTA lavender top tube).
Stability
- Room temperature: 3-5 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
- Neural Regen Res. 2012;7: 2842-7. [PMID: 25317135]
- Eur J Hum Genet. 2010;18: 1176-7. [PMID: 20179742]
- J Clin Lab Anal. 2003;17: 195-200. [PMID: 12938149]
- Arch Neurol. 2002;59: 623-9. [PMID: 11939898]
- Am J Med Genet. 2000;95: 351-7. [PMID: 11186889]
- Arch Neurol. 2000;58: 1821-7. [PMID: 11708990]
- Hum Mol Genet. 1996;5: 207-13. [PMID: 8824876]
- Am J Hum Genet. 1995;57: 54-61. [PMID: 7611296]